Qiming-Backed AI Drug Discovery Startup Insilico Medicine Files For Hong Kong IPO Forbes Nawigacja wpisu Hong Kong-based biotech Insilico Medicine shifts IPO plan to city from New York – South China Morning Post Newsworthy from the School of Medicine, Week of June 23 – June … – UNC Health and UNC School of Medicine
